Author

Pradeep P. Kayampilly

University of MichiganORCID 0009-0002-3486-9532Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Ahmed Abdel‐LatifiD· 1 shared Alethia Dixon· 1 shared Anand Singh· 1 shared Charles A. StewardiD· 1 shared Jessica Sim· 1 shared Keith Louis SaumiD· 1 shared Lixia ZengiD· 1 shared Subramaniam PennathuriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Ahmed Abdel‐LatifORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Sotagliflozin Reprograms Hepatic Lipid Metabolism and Attenuates Atherosclerosis Beyond Empagliflozin in CKM Mice

Keith Louis Saum, Jessica Sim, Lixia Zeng, Charles A. Steward, Pradeep P. Kayampilly, Alethia Dixon, Anand Singh, Ahmed Abdel‐Latif, Subramaniam Pennathur

This study compares sotagliflozin and empagliflozin in CKM mice, finding sotagliflozin more effectively reduces atherosclerosis and metabolic syndrome through hepatic lipid metabolism reprogramming.

bioRxiv · Oct 1, 2026 · PreprintPharmacology & Toxicology